Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive 10,000-Person study tests new tetanus shot

NCT ID NCT07107932

Summary

This study is observing a new injection, Siltartoxatug, given to prevent tetanus after someone gets injured. It will follow 10,000 patients for 90 days to see if they develop tetanus and to check for any side effects. The goal is to gather real-world information on how well this shot works and how safe it is for preventing this serious infection.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TETANUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shaoxing Central Hospital

    RECRUITING

    Shaoxing, Zhejiang, 312030, China

    Contact Phone: •••-•••-••••

  • The Second Affiliated Hospital of Shantou University

    NOT_YET_RECRUITING

    Shantou, Guangdong, 515041, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xiangyun County People's Hospital

    NOT_YET_RECRUITING

    Xiangyun, Yunnan, 672100, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhoushan Putuo District People's Hospital

    NOT_YET_RECRUITING

    Zhoushan, Zhejiang, 316100, China

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.